Fundraising FoxPermeasis
Boston, US · 1 known investors
Find your way into Permeasis
Sign up to see every warm intro you have to Permeasis
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Permeasis team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Permeasis Therapeutics is developing a Membrane Translocation Domain (MTD) platform that enables intracellular delivery of proteins and other large therapeutic macromolecules to the cytosol and intracellular compartments. The company initially targets genetically defined diseases where delivering functional proteins inside cells could have therapeutic impact.
Investors · 1
Frequently asked questions
- What does Permeasis do?
- Permeasis Therapeutics is developing a Membrane Translocation Domain (MTD) platform that enables intracellular delivery of proteins and other large therapeutic macromolecules to the cytosol and intracellular compartments. The company initially targets genetically defined diseases where delivering functional proteins inside cells could have therapeutic impact.
- Who are Permeasis's investors?
- Permeasis's investors include Cure Ventures.
- Where is Permeasis headquartered?
- Permeasis is headquartered in Boston, US.